J.-P. Chaput, S. St-Pierre and A. Tremblay Pages 3 - 10 ( 8 )
The currently available drugs for long-term treatment of obesity are sibutramine and orlistat. They have been shown to be able to induce significant weight loss, with important co-morbidity reduction, allowing the maintenance of reduced body weight for at least 1-2 years. Cardiostimulating and gastrointestinal adverse effects are however not negligible.
Pharmacotherapy, sibutramine, orlistat, body weight, fat, energy balance, physical activity, diet
Division of Kinesiology (PEPS), Laval University, Sainte-Foy, Québec, Canada, G1K 7P4.